Promising One Year Results For Renal Denervation In Resistant Hypertension...
Denervation of the renal sympathetic nerve may become an important new tool in the fight against resistant hypertension. Previously, the main results of the Symplicity HTN-2 trial demonstrated that in...
View Article5 Ways Social Media Takes Customer Relationships To The Next Level
To really connect with customers and build online communities, brands in heavily regulated industries need to think outside the box -- and use social as a way to encourage customers to connect with...
View ArticleDeveloping the Global Leader
What skills do today's executives need to develop to become effective global leaders of tomorrow? And how do corporations teach these skills to their own leaders?
View ArticleForbes Earnings Preview: St. Jude Medical
In the month leading up to the St. Jude Medical's (STJ) fourth quarter earnings announcement slated for Wednesday, January 23, 2013, expectations have risen for the upcoming results. The consensus...
View ArticleForbes Earnings Preview: Edwards Lifesciences
Wall Street is expecting higher profit for Edwards Lifesciences (EW) when the company reports its fourth quarter results on Monday, February 4, 2013. The consensus estimate is calling for profit of 77...
View ArticleForbes Earnings Preview: Medtronic
Medtronic (MDT) reports its third quarter earnings on Tuesday, February 19, 2013. The consensus estimate is 91 cents per share, up 8.3% from a year ago when Medtronic reported earnings of 84 cents per...
View ArticleFDA Approves Second Generation MRI-Friendly Pacemaker System From Medtronic
Medtronic announced today that the FDA had approved its Advisa DR MRI SureScan, a next generation pacemaker system specifically designed and tested for use with MRI scanners. The system, which...
View ArticleBrain Implants Help Parkinson's Patients
DeutsBrain stimulation for Parkinson's disease. (Photo credit: Wikipedia) A study in the New England Journal of Medicine shows that deep brain stimulation, a therapy in which an device is implanted in...
View ArticleBoston Scientific's PREVAIL Fail Revisited: Spinning The Truth
The biggest story at the American College of Cardiology meeting last week was the missing story. As reported here and just about everywhere else, the PREVAIL trial, probably the most-anticipated...
View ArticleCash Dividend On The Way From Medtronic
Looking at the universe of stocks we cover at Dividend Channel, on 4/3/13, Medtronic, Inc. (NYSE: MDT) will trade ex-dividend, for its quarterly dividend of $0.26, payable on 4/26/13. As a percentage...
View ArticleTwo Painless Medicine Companies Look to Gain Scale
Two clinical-stage medical companies are working on making painful needles a thing of the past, writes Mergermarket's Ilene Friedland
View ArticleNotable ETF Inflow Detected - VHT, ESRX, MDT, BAX
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Health Care ETF (AMEX: VHT) where we have detected an...
View ArticleBLOCK HF: CRT Superior To Conventional Pacing In Heart Failure Patients With...
Patients with atrioventricular (AV) block generally receive right ventricular pacing; cardiac resynchronization therapy (CRT) has been restricted to patients with a low ejection fraction and a wide QRS...
View ArticleVanguard Total Stock Market ETF Experiences Big Inflow
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Total Stock Market ETF (AMEX: VTI) where we have detected an...
View ArticleWhy Apple Isn't Rotting
Here's why investors should still be bullish on Apple and these four other former growth-stock darlings.
View ArticleWhat Is Authentic Leadership?
What is authentic leadership? It continues to surprise me how many leaders attempt to be one way at work, while their “true” personality emerges outside of work. Once a CEO reminded me, “Leadership is...
View ArticleForbes Earnings Preview: Medtronic
Medtronic (MDT) reports its fourth quarter earnings on Tuesday, May 21, 2013. The consensus estimate is $1.03 per share, up 4% from a year ago when Medtronic reported earnings of 99 cents per share....
View ArticleProtest outside Facebook's New York Office
Protesters descend on Facebook’s New York City headquarters to demand the company appoint women to it’s all male board before it goes public.
View ArticleThe Crucial Edge That Makes A Board Exceptional
This article is by Punit Renjen, the chairman of the board of Deloitte LLP. Which of the following is the mark of a great board room, (a) an eyebrow raised, and then a hand, quickly followed by a...
View Article
